EP2477648
SYNERGISTIC ANTI-CD47 THERAPY FOR HEMATOLOGIC CANCERS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
15.9.2010EP published:
20.7.2022EP application number:
10817793.2
EPO information:
European Patent Register
Max expiry date:
14.9.2030
Title in English:
SYNERGISTIC ANTI-CD47 THERAPY FOR HEMATOLOGIC CANCERSLanguage of the patent:
English
Timeline
Today
15.9.2010EP application
20.7.2022EP Publication
Owner
Name:
The Board of Trustees of the Leland Stanford Junior UniversityAddress:
Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038, US
Inventor
Name:
WEISSMAN, Irving L.Address:
Stanford, CA 94305, US
Name:
MAJETI, RavindraAddress:
Stanford, CA 94304, US
Name:
ALIZADEH, Arash AshAddress:
San Mateo, CA 94403, US
Name:
CHAO, Mark P.Address:
Mountain View, CA 94040, US
Priority
Number:
276726 PDate:
15.9.2009Country:
US
Classification
Categories:
A61K 39/00, C12P 21/08, C07K 16/28